Aveanna Healthcare Holdings Inc. AVAH
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- +60.59%
- 1 year
- +44.97%
- Open
- 13.27
- Prev close
- 13.16
- Mkt cap
- 2.86B
- Vol
- 3.01M
- Avg vol
- 3.04M
- EPS
- 1.26
- P/E
- 10.41
- Div yield
- 0.00%
More statistics
- Low
- 12.89
- High
- 13.46
- Forward P/E
- 14.45
- Beta
- 2.01
- Short ratio
- 1.72
- Inst. own
- 94.18%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 13.10
- 200-d avg
- 9.23
- 1y target
- 15.05
News
5 days ago zacks.com
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
1 week ago globenewswire.com
Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference Call
ATLANTA, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open…
2 weeks ago zacks.com
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Here is how Aveanna Healthcare (AVAH) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
2 weeks ago zacks.com
Implied Volatility Surging for Aveanna Healthcare Stock Options
Investors need to pay close attention to AVAH stock based on the movements in the options market lately.
3 weeks ago seekingalpha.com
Top Healthcare Stocks: Playing Offense And Defense For The Win
Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for…
3 weeks ago zacks.com
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
3 weeks ago zacks.com
Will Aveanna (AVAH) Beat Estimates Again in Its Next Earnings Report?
Aveanna (AVAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
1 month ago defenseworld.net
Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Down – Should You Sell?
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH - Get Free Report) shares gapped down prior to trading on Wednesday. The stock had previously closed at $12.78, but opened at $12.29. Aveanna Healthcare…
1 month ago zacks.com
Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
Here is how Aveanna Healthcare (AVAH) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
1 month ago zacks.com
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
1 month ago zacks.com
5 Top-Ranked Stocks Likely to Deliver Earnings Beats
Top-ranked stocks AVAH, FTNT, THC, ARW and VLO are likely to beat on the bottom line in their upcoming releases.
1 month ago zacks.com
Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
1 month ago seekingalpha.com
Aveanna Healthcare Holdings Inc. (AVAH) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Aveanna Healthcare Holdings Inc. (AVAH) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
1 month ago benzinga.com
Jim Cramer: Buy This Energy Stock, It Is ‘Terrific’
Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculative, and supported holding Aveanna.
1 month ago zacks.com
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
-
1 month ago benzinga.com
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
1 month ago benzinga.com
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential momentum warnings for healthcare investors.
1 month ago defenseworld.net
Hsbc Holdings PLC Takes Position in Aveanna Healthcare Holdings Inc. $AVAH
Hsbc Holdings PLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) in the undefined quarter, according to the company in its most recent Form 13F filing with the…
2 months ago zacks.com
Is Aveanna Healthcare (AVAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
2 months ago defenseworld.net
87,800 Shares in Aveanna Healthcare Holdings Inc. $AVAH Purchased by Canada Pension Plan Investment Board
Canada Pension Plan Investment Board bought a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) in the second quarter, according to its most recent disclosure with the Securities and…
2 months ago seekingalpha.com
Aveanna Healthcare: Increasing Earnings And Delevering Focus Make It An Appealing Stock
Aveanna Healthcare Holdings demonstrates strong revenue and earnings growth, with a focus on private duty services and strategic M&A. AVAH trades at a low LTM P/E of 11.8x, reflecting its high…
2 months ago zacks.com
4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
-
2 months ago benzinga.com
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.
2 months ago zacks.com
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
-
2 months ago benzinga.com
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $11 to $15.
-
2 months ago benzinga.com
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16
RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $16.
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday's pre-market session. The company's market cap stands at $20.9 million. Jupiter Neurosciences…
2 months ago benzinga.com
Flowers Foods Posts Downbeat Q2 Results, Joins OSI Systems, Aveanna Healthcare And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
US stock futures rise, Dow up 150 points. Flowers Foods (NYSE:FLO) plunges on poor earnings & lowered forecast. Other stocks also down in pre-market.
2 months ago benzinga.com
Why Ross Stores Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI, HOWL, SUGP, SDEV, ZKH, BTAI, SXTC, TREO, and ASST. Losers are JZ, DFNS, FLUX, and MMA.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday's after-market session. The company's market cap stands at $19.8 million. Profusa (NASDAQ:PFSA) stock…
-
2 months ago benzinga.com
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $13.
-
2 months ago benzinga.com
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15
Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and raises the price target from $13 to $15.
-
2 months ago benzinga.com
BMO Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $14
BMO Capital analyst Sean Dodge maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $14.
2 months ago benzinga.com
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday
Nasdaq Composite gained 200 points on Thursday, while Accelerant Holdings (NYSE: ARX) rose 44.2% after being acquired by Thoma Bravo and reporting strong Q2 results. Other top gainers include Omeros…
-
2 months ago benzinga.com
Aveanna Healthcare Q2 Adj. EPS $0.22 Beats $0.17 Estimate, Sales $670.483M Beat $638.619M Estimate
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.17 by 29.41 percent. This is a 22.22 percent increase over…
-
3 months ago benzinga.com
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $11
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $9 to $11.
-
3 months ago benzinga.com
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $9.5
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9 to $9.5.
-
5 months ago benzinga.com
RBC Capital Upgrades Aveanna Healthcare Hldgs to Outperform, Maintains Price Target to $10
RBC Capital analyst Ben Hendrix upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Sector Perform to Outperform and maintains the price target from $10 to $10.
5 months ago benzinga.com
Aveanna Raises Outlook After Family First Buy
Aveanna Healthcare ($AVAH) boosts 2026 guidance, projecting up to $2.65B in revenue and $342M in adjusted EBITDA after Family First buyout.
-
5 months ago benzinga.com
Aveanna Healthcare Hldgs Raises FY2026 Sales Guidance from $2.560B-$2.580B to $2.630B-$2.650B vs $2.559B Est
Aveanna Healthcare Hldgs (NASDAQ:AVAH) raises FY2026 sales outlook from $2.560 billion-$2.580 billion to $2.630 billion-$2.650 billion vs $2.559 billion estimate.
-
5 months ago benzinga.com
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $9
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $8 to $9.
-
5 months ago benzinga.com
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $9.5 to $9.
-
5 months ago benzinga.com
Stephens & Co. Upgrades Aveanna Healthcare Hldgs to Overweight, Raises Price Target to $11
Stephens & Co. analyst Scott Fidel upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Equal-Weight to Overweight and raises the price target from $10 to $11.
-
5 months ago benzinga.com
RBC Capital Maintains Sector Perform on Aveanna Healthcare Hldgs, Raises Price Target to $10
RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sector Perform and raises the price target from $9 to $10.
5 months ago benzinga.com
Aveanna Healthcare Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript
Aveanna Healthcare Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript
-
5 months ago benzinga.com
Aveanna Healthcare Hldgs Raises FY2026 Sales Guidance from $2.540B-$2.560B to $2.560B-$2.580B vs $2.559B Est
Full Year 2026 GuidanceThe following is our guidance reflecting our increased expectations for revenue and Adjusted EBITDA for the full fiscal year 2026 (year ending January 2, 2027):Revenue of…
-
5 months ago benzinga.com
Aveanna Healthcare Hldgs Q1 Adj. EPS $0.18 Beats $0.13 Estimate, Sales $647.915M Beat $613.191M Estimate
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.13 by 38.46 percent. This is a 80 percent increase over earnings…
-
5 months ago benzinga.com
Centers For Medicare & Medicaid Services Announces Six-Month Moratoria On Hospice And Home Health Agency Registrations, Citing Fraud Crackdown
https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-month-hospice-home-health-agency-enrollment
-
7 months ago benzinga.com
Earnings Scheduled For March 19, 2026
Earnings Scheduled For March 19, 2026